MDVN Astellas and Medivation Submit Supplemental New Drug Application for XTANDI (Enzalutamide) for Ch... http://finance.yahoo.com/news/astellas-medivation-submit-supplemental-drug-110000020.html?soc_src=mediacontentstory via @YahooFinance